0000899243-18-011956.txt : 20180508
0000899243-18-011956.hdr.sgml : 20180508
20180508200043
ACCESSION NUMBER: 0000899243-18-011956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180504
FILED AS OF DATE: 20180508
DATE AS OF CHANGE: 20180508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Legleiter Rick L
CENTRAL INDEX KEY: 0001718503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52607
FILM NUMBER: 18816355
MAIL ADDRESS:
STREET 1: UNIVERSAL BIOSENSORS, INC.
STREET 2: 1 CORPORATE AVENUE
CITY: ROWVILLE
STATE: C3
ZIP: 3178
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNIVERSAL BIOSENSORS INC
CENTRAL INDEX KEY: 0001279695
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980424072
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1 CORPORATE AVENUE
STREET 2: ROWVILLE
CITY: VICTORIA
STATE: C3
ZIP: 3178
BUSINESS PHONE: 613-9213-9000
MAIL ADDRESS:
STREET 1: 1 CORPORATE AVENUE
STREET 2: ROWVILLE
CITY: VICTORIA
STATE: C3
ZIP: 3178
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-04
0
0001279695
UNIVERSAL BIOSENSORS INC
UBI
0001718503
Legleiter Rick L
1 CORPORATE AVENUE
ROWVILLE
VICTORIA
C3
3178
AUSTRALIA
0
1
0
0
Chief Executive Officer
Common Stock
2018-05-04
4
P
0
158687
0.2585
A
158687
D
Stock Option (Right to Buy)
0.50
2022-10-23
Common Stock
1600000
1600000
D
Stock Option (Right to Buy)
0.60
2022-10-23
Common Stock
2700000
2700000
D
Stock Option (Right to Buy)
0.80
2022-10-23
Common Stock
3300000
3300000
D
Traded as Chess Depository Interests ("CDIs") on the Australian Stock Exchange. CDIs represent beneficial interests in the common stock held by CHESS Depository Nominees Pty Ltd.
The price reported in Column 4 is a weighted average price and is stated in Australian dollars. These shares were purchased in multiple transactions at prices ranging from AU$0.24 to AU$0.27. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The price reported is stated in Australian dollars.
The options were granted on October 24, 2017. The options will vest and only become exercisable on the date that is three years from the date of grant of the options, subject to continued employment at the time of vesting. If the Company terminates the employment without cause prior to the vesting date, a proportion of the options will vest, being the same as the proportion of the three year vesting period that the employee served with the Company.
/s/ Cameron Billingsley, Attorney in Fact
2018-05-08